Physician

Afshine A Emrani, MD

According to 2025 Medicare claims, Afshine Emrani, MD (NPI: 1356360887) practices cardiology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is LOS ANGELES HEART SPECIALIST MEDICAL CORP (NPI: 1194750679; TIN: 460503597) and primary practice location at 91356-2842.

Emrani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,372 traditional Medicare patients, billed 370,182 HCPCS/CPT codes, and received $6,731,484 in Medicare payments. The top billing code was 82728 (Ferritin (blood protein) level). Part D data shows 33,117 prescription claims across 1,259 beneficiaries totaling $8,621,713 in drug costs, led by Prolia (Denosumab). DME data shows 610 claims. Open Payments data shows 178 records totaling $4,491. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,949,830 to $6,731,484. Similarly, Part D prescription costs have risen steadily, from $4,057,482 to $8,621,713. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $53,486 to $78,281.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	908	105,286	$1,949,830
2016	976	112,003	$2,141,405
2017	1,074	117,561	$2,309,415
2018	1,180	149,443	$2,638,897
2019	1,246	145,509	$2,575,556
2020	1,344	118,417	$2,325,830
2021	1,447	124,543	$2,803,066
2022	1,430	124,466	$3,047,770
2023	1,389	234,015	$5,074,029
2024	1,372	370,182	$6,731,484

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	793	26,325	$4,057,482
2016	866	27,306	$5,678,925
2017	902	27,240	$6,066,397
2018	1,036	28,810	$7,129,716
2019	1,107	31,370	$7,844,624
2020	1,230	33,254	$8,090,454
2021	1,291	33,538	$8,753,837
2022	1,351	34,618	$10,492,555
2023	1,306	35,136	$11,363,316
2024	1,259	33,117	$8,621,713

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	209	1,015	$44,384
2016	148	658	$13,547
2017	156	549	$19,559
2018	103	444	$7,060
2019	114	454	$8,091
2020	137	474	$6,154
2021	135	539	$18,204
2022	218	785	$45,461
2023	195	763	$60,674
2024	117	610	$67,202

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82728	Ferritin (blood protein) level	1,255	3,334	$13
80061	Blood test, lipids (cholesterol and triglycerides)	1,255	3,417	$13
80076	Liver function blood test panel	1,255	3,466	$8
83540	Iron level	1,256	3,342	$6
84550	Uric acid level, blood	1,256	3,451	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolia	Denosumab	505	90,810	$884,713
Repatha Sureclick	Evolocumab	895	32,069	$604,907
Vascepa	Icosapent Ethyl	1,347	50,827	$571,749
Ozempic	Semaglutide	413	15,942	$496,663
Eliquis	Apixaban	557	24,900	$481,799

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	27	152	$54,401
E0277	Powered pressure-reducing air mattress	Y	N/R	15	$1,983
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	19	$1,978
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	26	$1,362
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	43	92	$1,352

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	178	$4,491	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Afshine A. Emrani, MD?

Tedicare shows public-source Medicare data for Afshine A. Emrani, MD (NPI 1356360887), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Afshine A. Emrani, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Afshine A. Emrani, MD?

Afshine A. Emrani, MD is linked to LOS ANGELES HEART SPECIALIST MEDICAL CORP (billing NPI 1194750679) in the available physician profile data.

Does Afshine A. Emrani, MD have Open Payments data?

Afshine A. Emrani, MD has 178 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.